Who we are
BMG Pharma is involved in the development of new healthcare products in the areas of oral care and dermatology including aesthetics, anemia, osteoarthritis.
Our company has created a strong portfolio of intellectual property which it has developed into a number of products that have been partnered with companies around the world.
Our company recently merged with Sigea, an Italian firm with expertise in targeted functional ingredients development. They are currently focused on modified sodium hyaluronate for applications in a number of therapeutic areas, including dermatology and oral care. This merger will allow BMG to accelerate the development of several new products to complement its portfolio.